The Reality Of Rebound Infection Setting In For Corporate Media
Paxlovid Is Failing At Viral Clearance
Despite the not-very-credible denials by Pfizer that rebound infection is a significant phenomenon with Paxlovid, the corporate media is being compelled to admit what critically thinking people have recognized for some time: Paxlovid is failing at viral clearance.
And yet, nearly a month after National Institute of Health officials said they needed to get “an urgent handle on the issue,” researchers are still struggling to understand the phenomenon, largely because no one has any idea how common it is or any way to track it.
The ignorance of the “experts” researching the phenomenon would be laughable if people's health and well-being were not at stake. The reality of rebound infection has already been amply documented and discussed among the (hopefully growing) ranks of critical thinkers not beholden to the lies of the Pandemic Panic Narrative.
Reality wins, every time.